Min L - Search Results

1

Long-term safety of pembrolizumab monotherapy and relationship with clinical outcome: A landmark analysis in patients with advanced melanoma.

Robert C, Hwu WJ, Hamid O, Ribas A, Weber JS, Daud AI, Hodi FS, Wolchok JD, Mitchell TC, Hersey P, Dronca R, Joseph RW, Boutros C, Min L, Long GV, Schachter J, Puzanov I, Dummer R, Lin J, Ibrahim N, Diede SJ, Carlino MS, Joshua AM. Robert C, et al. Among authors: min l. Eur J Cancer. 2021 Feb;144:182-191. doi: 10.1016/j.ejca.2020.11.010. Epub 2020 Dec 24. Eur J Cancer. 2021. PMID: 33360855 Free PMC article.

2

Thyroid autoimmunity and ophthalmopathy related to melanoma biological therapy.

Min L, Vaidya A, Becker C. Min L, et al. Eur J Endocrinol. 2011 Feb;164(2):303-7. doi: 10.1530/EJE-10-0833. Epub 2010 Nov 18. Eur J Endocrinol. 2011. PMID: 21088057 Free PMC article.

3

Ipilimumab-induced autoimmune adrenalitis.

Min L, Ibrahim N. Min L, et al. Lancet Diabetes Endocrinol. 2013 Nov;1(3):e15. doi: 10.1016/S2213-8587(13)70031-7. Epub 2013 Jul 9. Lancet Diabetes Endocrinol. 2013. PMID: 24622375 Free PMC article. No abstract available.

4

Anti-PD1 following ipilimumab for mucosal melanoma: durable tumor response associated with severe hypothyroidism and rhabdomyolysis.

Min L, Hodi FS. Min L, et al. Cancer Immunol Res. 2014 Jan;2(1):15-8. doi: 10.1158/2326-6066.CIR-13-0146. Epub 2013 Oct 7. Cancer Immunol Res. 2014. PMID: 24778161 Free PMC article.

5

Systemic high-dose corticosteroid treatment does not improve the outcome of ipilimumab-related hypophysitis: a retrospective cohort study.

Min L, Hodi FS, Giobbie-Hurder A, Ott PA, Luke JJ, Donahue H, Davis M, Carroll RS, Kaiser UB. Min L, et al. Clin Cancer Res. 2015 Feb 15;21(4):749-55. doi: 10.1158/1078-0432.CCR-14-2353. Epub 2014 Dec 23. Clin Cancer Res. 2015. PMID: 25538262 Free PMC article.

6

Corticosteroids and immune checkpoint blockade.

Min L, Hodi FS, Kaiser UB. Min L, et al. Aging (Albany NY). 2015 Aug;7(8):521-2. doi: 10.18632/aging.100797. Aging (Albany NY). 2015. PMID: 26298620 Free PMC article. No abstract available.

7

Gene expression profiling of anti-CTLA4-treated metastatic melanoma in patients with treatment-induced autoimmunity.

Bresler SC, Min L, Rodig SJ, Walls AC, Xu S, Geng S, Hodi FS, Murphy GF, Lian CG. Bresler SC, et al. Among authors: min l. Lab Invest. 2017 Feb;97(2):207-216. doi: 10.1038/labinvest.2016.126. Epub 2016 Dec 5. Lab Invest. 2017. PMID: 27918555 Free article.

8

Incidence of Endocrine Dysfunction Following the Use of Different Immune Checkpoint Inhibitor Regimens: A Systematic Review and Meta-analysis.

Barroso-Sousa R, Barry WT, Garrido-Castro AC, Hodi FS, Min L, Krop IE, Tolaney SM. Barroso-Sousa R, et al. Among authors: min l. JAMA Oncol. 2018 Feb 1;4(2):173-182. doi: 10.1001/jamaoncol.2017.3064. JAMA Oncol. 2018. PMID: 28973656 Free PMC article.

9

Characterization of Thyroid Disorders in Patients Receiving Immune Checkpoint Inhibition Therapy.

Lee H, Hodi FS, Giobbie-Hurder A, Ott PA, Buchbinder EI, Haq R, Tolaney S, Barroso-Sousa R, Zhang K, Donahue H, Davis M, Gargano ME, Kelley KM, Carroll RS, Kaiser UB, Min L. Lee H, et al. Among authors: min l. Cancer Immunol Res. 2017 Dec;5(12):1133-1140. doi: 10.1158/2326-6066.CIR-17-0208. Epub 2017 Oct 27. Cancer Immunol Res. 2017. PMID: 29079654 Free PMC article.

10

Endocrine dysfunction induced by immune checkpoint inhibitors: Practical recommendations for diagnosis and clinical management.

Barroso-Sousa R, Ott PA, Hodi FS, Kaiser UB, Tolaney SM, Min L. Barroso-Sousa R, et al. Among authors: min l. Cancer. 2018 Mar 15;124(6):1111-1121. doi: 10.1002/cncr.31200. Epub 2018 Jan 3. Cancer. 2018. PMID: 29313945 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,201 results

Search Page